These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 25630292)
1. [Symptom based approaches in point of care laboratory testing]. Risch L; Senn O Ther Umsch; 2015 Feb; 72(2):105-12. PubMed ID: 25630292 [TBL] [Abstract][Full Text] [Related]
2. [Outcome studies with regard to medical laboratory testing]. Huber AR Ther Umsch; 2015 Feb; 72(2):93-8. PubMed ID: 25630290 [TBL] [Abstract][Full Text] [Related]
3. Dilution testing using rapid diagnostic tests in a HIV diagnostic algorithm: a novel alternative for confirmation testing in resource limited settings. Shanks L; Siddiqui MR; Abebe A; Piriou E; Pearce N; Ariti C; Masiga J; Muluneh L; Wazome J; Ritmeijer K; Klarkowski D Virol J; 2015 May; 12():75. PubMed ID: 25972188 [TBL] [Abstract][Full Text] [Related]
4. [Laboratory results in clinical practice: importance of interpretation in the clinical context]. Baumgartner A; Schuetz P Ther Umsch; 2015 Feb; 72(2):119-23. PubMed ID: 25630294 [TBL] [Abstract][Full Text] [Related]
5. Analytical performance, agreement and user-friendliness of six point-of-care testing urine analysers for urinary tract infection in general practice. Schot MJ; van Delft S; Kooijman-Buiting AM; de Wit NJ; Hopstaken RM BMJ Open; 2015 May; 5(5):e006857. PubMed ID: 25986635 [TBL] [Abstract][Full Text] [Related]
6. The need for a point of care testing: an evidence-based appraisal. Collinson PO Scand J Clin Lab Invest Suppl; 1999; 230():67-73. PubMed ID: 10389204 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of PIMA point-of-care CD4 testing in a large UK HIV service. Herbert S; Edwards S; Carrick G; Copas A; Sandford C; Amphlett M; Benn P Sex Transm Infect; 2012 Oct; 88(6):413-7. PubMed ID: 22544309 [TBL] [Abstract][Full Text] [Related]
8. Chlamydia point-of-care testing: where are we now? Jain A; Ison CA Sex Transm Infect; 2013 Mar; 89(2):88-9. PubMed ID: 23423334 [No Abstract] [Full Text] [Related]
9. Point-of-care troponin T is inferior to high-sensitivity troponin T for ruling out acute myocardial infarction in the emergency department. Ter Avest E; Visser A; Reitsma B; Breedveld R; Wolthuis A Eur J Emerg Med; 2016 Apr; 23(2):95-101. PubMed ID: 25536392 [TBL] [Abstract][Full Text] [Related]
10. Three-month outcome of patients with suspected acute coronary syndrome using point-of-care cardiac troponin-T testing compared with laboratory-based cardiac troponin-T testing: a randomised trial. Asha SE; Cooke A; Walter E; Weaver J Emerg Med J; 2015 Aug; 32(8):601-7. PubMed ID: 25261004 [TBL] [Abstract][Full Text] [Related]
11. Integration between point-of-care cardiac markers in an emergency/cardiology department and the central laboratory: methodological and preliminary clinical evaluation. Di Serio F; Amodio G; Varraso L; Campaniello M; Coluccia P; Trerotoli P; Antonelli G; Pansini N Clin Chem Lab Med; 2005; 43(2):202-9. PubMed ID: 15843218 [TBL] [Abstract][Full Text] [Related]
12. Comparison of D-dimer point of care test (POCT) against current laboratory test in patients with suspected venous thromboembolism (VTE) presenting to the emergency department (ED). Sen B; Kesteven P; Avery P J Clin Pathol; 2014 May; 67(5):437-40. PubMed ID: 24307452 [TBL] [Abstract][Full Text] [Related]
13. Rapid laboratory testing for trauma patients: where a perfect result may not be in the best interests of the patient. Callum JL; Rizoli S; Pendergrast J Transfusion; 2010 Dec; 50(12):2529-32. PubMed ID: 21126249 [No Abstract] [Full Text] [Related]
14. ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study. Broadhurst MJ; Kelly JD; Miller A; Semper A; Bailey D; Groppelli E; Simpson A; Brooks T; Hula S; Nyoni W; Sankoh AB; Kanu S; Jalloh A; Ton Q; Sarchet N; George P; Perkins MD; Wonderly B; Murray M; Pollock NR Lancet; 2015 Aug; 386(9996):867-74. PubMed ID: 26119838 [TBL] [Abstract][Full Text] [Related]
15. Field-testing and validation in a primary care setting of a point-of-care test for C-reactive protein. Seamark DA; Backhouse SN; Powell R Ann Clin Biochem; 2003 Mar; 40(Pt 2):178-80. PubMed ID: 12662408 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices. Shephard MD; Mazzachi BC; Watkinson L; Shephard AK; Laurence C; Gialamas A; Bubner T Rural Remote Health; 2009; 9(3):1189. PubMed ID: 19689171 [TBL] [Abstract][Full Text] [Related]
17. The role of D-dimer testing in patients with suspected venous thromboembolism. Prisco D; Grifoni E Semin Thromb Hemost; 2009 Feb; 35(1):50-9. PubMed ID: 19308893 [TBL] [Abstract][Full Text] [Related]
18. Overestimation of test effects in clinical judgment. Lyman GH; Balducci L J Cancer Educ; 1993; 8(4):297-307. PubMed ID: 8186081 [TBL] [Abstract][Full Text] [Related]
19. The effect of changing disease risk on clinical reasoning. Lyman GH; Balducci L J Gen Intern Med; 1994 Sep; 9(9):488-95. PubMed ID: 7996291 [TBL] [Abstract][Full Text] [Related]
20. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS). Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]